Risk factors for breakthrough invasive fungal infection during secondary prophylaxis.
Cornely OA, Böhme A, Reichert D, Reuter S, Maschmeyer G, Maertens J, Buchheidt D, Paluszewska M, Arenz D, Bethe U, Effelsberg J, Lövenich H, Sieniawski M, Haas A, Einsele H, Eimermacher H, Martino R, Silling G, Hahn M, Wacker S, Ullmann AJ, Karthaus M; Multinational Case Registry of the Infectious Diseases Working Party of the German Society for Hematology and Oncology.
Cornely OA, et al. Among authors: reuter s.
J Antimicrob Chemother. 2008 Apr;61(4):939-46. doi: 10.1093/jac/dkn027. Epub 2008 Feb 12.
J Antimicrob Chemother. 2008.
PMID: 18272515